Lincoln Capital’s Idexx Laboratories IDXX Stock Holding History

Lincoln Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.57M	Hold	2,990	–	–	0.28%	53
2026 Q1	$1.68M	Sell	2,990 -37	-1%	-$23.7K	0.32%	45
2025 Q4	$2.05M	Hold	3,027	–	–	0.37%	44
2025 Q3	$1.91M	Sell	3,027 -3	-0.1%	-$1.82K	0.36%	46
2025 Q2	$1.62M	Buy	3,030 +2	+0.1%	+$956	0.31%	48
2025 Q1	$1.28M	Buy	+3,028	New	+$1.31M	0.27%	53

Other funds holding IDXX

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

WJWM

Williams Jones Wealth Management New York $8.86B AUM 22.16% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

Lincoln Capital's IDXX Position: Q2 2026 in Review

Lincoln Capital held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 2,990 shares worth $1.57M. The position accounts for 0.28% of the portfolio, ranked #53.

Lincoln Capital first reported a position in IDXX in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.05M in Q4 2025. 612 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Lincoln Capital held 2,990 shares of Idexx Laboratories worth $1.57M as of Q2 2026.
Lincoln Capital left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 0.28% of Lincoln Capital's portfolio in Q2 2026, its #53 holding.
Lincoln Capital first reported a position in Idexx Laboratories in Q1 2025 and has held it in 6 quarters since.
Lincoln Capital's Idexx Laboratories position peaked at $2.05M in Q4 2025.
612 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Lincoln Capital's 13F filing for Q2 2026, filed 7 Jul 2026.